Economic evaluation of drugs: a UK pharmaceutical industry perspective.
Glaxo Pharmaceuticals UK Limited, Uxbridge, England.
N
N
Wells
D003363:Cost Control; D003362:Cost-Benefit Analysis; D004345:Drug Industry; D017850:Economics, Pharmaceutical; D005069:Evaluation Studies as Topic; D005544:Forecasting; D015276:Health Care Rationing / Q000191:economics; D005102:Health Expenditures; D006801:Humans; D011788:Quality of Life; D006113:United Kingdom